Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Catalyst Pharmaceuticals Inc CPRX

Healthcare Biotechnology
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing first-in-class medicines that address rare and difficult to treat diseases. Its flagship commercial product is FIRDAPSE (amifampridine) tablets 10 milligrams (mg), approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) for adults and for... see more

Recent & Breaking News (NDAQ:CPRX)

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc.

Business Wire December 6, 2013

SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX

Globe Newswire December 2, 2013

Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Catalyst Pharmaceutical Partners, Inc.

Business Wire November 27, 2013

Pomerantz Law Firm Has Filed a Class Action Against Catalyst Pharmaceutical Partners, Inc. and Certain Officers -- CPRX

Globe Newswire November 22, 2013

Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc.

Business Wire November 18, 2013

Catalyst Pharmaceutical Partners Announces Third Quarter 2013 Financial Results

Globe Newswire November 14, 2013

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc.

Business Wire November 12, 2013

Attention Catalyst Investors: Catalyst Pharmaceutical Partners Misled Investors According to a Newly Filed Class Action

PR Newswire November 12, 2013

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX)

Marketwired October 31, 2013

Catalyst Pharmaceutical Announces Social Media Presence

Globe Newswire October 30, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Catalyst Pharmaceutical Partners, Inc. to Contact the Firm

Marketwired October 29, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in Catalyst Pharmaceutical Partners, Inc. to Contact Brower Piven Before the December 24, 2013 Lead Plaintiff Deadline -- CPRX

Globe Newswire October 29, 2013

Catalyst Pharmaceutical Updates on Its Development Activities for Firdapse(TM)

Globe Newswire October 29, 2013

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Catalyst Pharmaceutical Partners Inc.

PR Newswire October 28, 2013

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX

Globe Newswire October 28, 2013

The Rosen Law Firm Files Securities Fraud Class Action Against Catalyst Pharmaceutical Partners, Inc. - CPRX

Business Wire October 25, 2013

The Rosen Law Firm Announces Investigation of Securities Claims Against Catalyst Pharmaceutical Partners, Inc.- CPRX

Business Wire October 21, 2013

Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Catalyst Pharmaceutical Partners, Inc.

Business Wire October 18, 2013

Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase lll Clinical Trial for Firdapse(TM)

Globe Newswire October 15, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on CPRX, HOLX, ROVI and SPR

Accesswire September 25, 2013